当前位置:首页 - 行情中心 - 大洋生物(003017) - 财务分析 - 现金流量表

大洋生物

(003017)

  

流通市值:23.18亿  总市值:28.10亿
流通股本:6928.80万   总股本:8400.00万

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金204,160,896.47969,065,747.87645,725,620.44411,750,321.67
  收到的税费返还3,495,734.5716,561,187.3923,032,674.3715,111,664.92
  收到其他与经营活动有关的现金14,296,158.133,234,755.0725,361,626.9320,281,445.02
  经营活动现金流入小计221,952,789.141,018,861,690.33694,119,921.74447,143,431.61
  购买商品、接受劳务支付的现金156,470,686.75650,647,745.41428,494,582.57229,069,598.05
  支付给职工以及为职工支付的现金40,970,111.82119,091,570.9288,001,937.4561,707,141.91
  支付的各项税费15,133,173.0348,449,772.2438,524,509.1625,744,044.97
  支付其他与经营活动有关的现金12,575,768.7840,566,691.7725,318,669.4617,254,670.93
  经营活动现金流出小计225,149,740.38858,755,780.34580,339,698.64333,775,455.86
  经营活动产生的现金流量净额-3,196,951.24160,105,909.99113,780,223.1113,367,975.75
二、投资活动产生的现金流量:
  收回投资收到的现金10,000,000152,941,989.588,000,00071,000,000
  取得投资收益收到的现金47,207.242,909,003.98807,031.44581,027.61
  处置固定资产、无形资产和其他长期资产收回的现金净额70,0003,934,150.4--
  收到的其他与投资活动有关的现金--493,098.74-
  投资活动现金流入小计10,117,207.24159,785,143.8889,300,130.1871,581,027.61
  购建固定资产、无形资产和其他长期资产支付的现金42,633,462.7776,384,580.2744,826,614.6627,156,127.02
  投资支付的现金-112,300,00048,000,00048,000,000
  投资活动现金流出小计42,633,462.77188,684,580.2792,826,614.6675,156,127.02
  投资活动产生的现金流量净额-32,516,255.53-28,899,436.39-3,526,484.48-3,575,099.41
三、筹资活动产生的现金流量:
  吸收投资收到的现金-3,900,0003,900,0001,940,000
  其中:子公司吸收少数股东投资收到的现金-3,900,0003,900,0001,940,000
  取得借款收到的现金215,000,000613,065,961.05556,000,000383,000,000
  收到其他与筹资活动有关的现金-14,955,956.2914,977,959.9612,266,823.8
  筹资活动现金流入小计215,000,000631,921,917.34574,877,959.96397,206,823.8
  偿还债务支付的现金164,442,333.34615,224,561.86562,532,232.75448,437,232.75
  分配股利、利润或偿付利息支付的现金846,071.5754,655,503.0628,249,319.5327,466,684.59
  支付其他与筹资活动有关的现金-4,853,589.154,405,438.734,440,642.4
  筹资活动现金流出小计165,288,404.91674,733,654.07595,186,991.01480,344,559.74
  筹资活动产生的现金流量净额49,711,595.09-42,811,736.73-20,309,031.05-83,137,735.94
四、汇率变动对现金及现金等价物的影响-962,776.98-232,637.5698,390.46577,899.16
五、现金及现金等价物净增加额13,035,611.3488,162,099.3790,643,098.0327,233,039.56
  加:期初现金及现金等价物余额435,406,539.53347,244,440.16347,244,440.16347,244,440.16
  期末现金及现金等价物余额448,442,150.87435,406,539.53437,887,538.19374,477,479.72
补充资料:
  净利润-100,064,311.65-50,295,967.72
  资产减值准备-18,941,020.93-13,679,742.76
  固定资产和投资性房地产折旧-69,033,818.04-30,764,320.36
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-69,033,818.04-30,764,320.36
  无形资产摊销-2,680,949.8-1,453,203.45
  长期待摊费用摊销-277,877.58-47,169.81
  处置固定资产、无形资产和其他长期资产的损失--2,049,686.99--
  固定资产报废损失-2,895,607.63-1,980,303.87
  公允价值变动损失-1,463,335.26--296,228.9
  财务费用-4,523,386.14-2,408,848.38
  投资损失--2,789,093.86-1,121,628.15
  递延所得税-1,247,427.44-6,914,161.51
  其中:递延所得税资产减少-4,958,461.74-5,608,278.02
    递延所得税负债增加--3,711,034.3-1,305,883.49
  存货的减少-9,878,925.86--1,482,081.81
  经营性应收项目的减少--128,734,389.8--6,535,572.39
  经营性应付项目的增加-68,786,868.48-12,585,981.49
  其他-13,050,400.34--
  现金的期末余额-435,406,539.53-374,477,479.72
  减:现金的期初余额-347,244,440.16-347,244,440.16
  现金及现金等价物的净增加额-88,162,099.37-27,233,039.56
公告日期2026-04-282026-04-282025-10-212025-08-26
审计意见(境内)标准无保留意见
TOP↑